Concepedia

Husain Attarwala

HA

Statistics

Publications

13

Citations

1.5K

H-Index

12

Active since

2010

Affiliations

Moderna Therapeutics (United States)(Current)

Alnylam Pharmaceuticals (United States)

Northeastern University

Puma Biotechnology (United States)

Husain Attarwala is an author at Moderna Therapeutics (United States) specializing in pharmacy, pharmacology, and immunology.

ORCID

Publications per year

2010–2024

13

Publications

13

An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia

Alfica Sehgal, Scott Barros, Lacramioara Ivanciu et al. · Nature Medicine · 2015 · 297 citations

, , +12

Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates

Jayaprakash K. Nair, Husain Attarwala, Alfica Sehgal et al. · Nucleic Acids Research · 2017 · 270 citations · Full text

, , +17

TGN1412: From Discovery to Disaster

Husain Attarwala · Journal of Young Pharmacists · 2010 · 255 citations · Full text

, , +15

A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus

Allison August, Husain Attarwala, Sunny Himansu et al. · Nature Medicine · 2021 · 186 citations · Full text

, , +17

Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects

Bahru Habtemariam, Verena Karsten, Husain Attarwala et al. · Clinical Pharmacology & Therapeutics · 2020 · 171 citations

, , +10

1–5 of 13